- Country: Germany
- Summary: Order Announcement - Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V for Drugs with the Active Ingredient Bimekizumab
- DET Ref No: 96717593
- Deadline: 10 Nov 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 85013-2024
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Section 130a Paragraph 8 SGB V enables health insurance companies (KK) and pharmaceutical companies to conclude framework discount agreements for the medicines to be supplied at the expense of the statutory KK. The GWQ is a society for efficiency and quality at KK in accordance with Section 130a Paragraph 8 Sentence 5 SGBV for its Ashareholder and customer funds. With regard to the relevant legal regulations for the awarding of public contracts, a regular process of active ingredient-related, formal award procedures takes place in accordance with the regulations of Part 4 of the GWB by GWQ ServicePlus AG. UntilWhen new drug discount agreements come into force, the GWQ would like to conclude drug discount agreements with all interested pharmaceutical companies. The contract starts on April 1st, 2024.
The following health insurance companies are taking part in this open house procedure:
Audi BKK
BAHN-BKK
Bertelsmann BKK
bkk melitta hmr
BIG direct healthy
BKK Akzo Nobel Bayern
BKK Deutsche Bank AG
BKK Diakonie
BKK DuerkoppAdler
BKK Faber-Castellb HellerIndexLeuze
BMW BKK
Mercedes-Benz BKK
BERGISCHE KRANKENKASSE
Home BKK
IKK Brandenburg and Berlin
IKK healthy plus
IKK - The Innovation Fund
IKK Suedwest
Koenig... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINOrder Announcement - Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V for Drugs with the Active Ingredient Bimekizumab - Germany Tender
The GWQ SERVICEPLUS AG, a Government sector organization in Germany, has announced a new tender for Order Announcement - Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V for Drugs with the Active Ingredient Bimekizumab. This tender is published on GermanyTenders under DET Ref No: 96717593 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-10.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
